BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9989582)

  • 1. FTDP-17 mutations N279K and S305N in tau produce increased splicing of exon 10.
    Hasegawa M; Smith MJ; Iijima M; Tabira T; Goedert M
    FEBS Lett; 1999 Jan; 443(2):93-6. PubMed ID: 9989582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
    Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
    Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
    Spillantini MG; Van Swieten JC; Goedert M
    Neurogenetics; 2000 Mar; 2(4):193-205. PubMed ID: 10983715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional effects of tau gene mutations deltaN296 and N296H.
    Yoshida H; Crowther RA; Goedert M
    J Neurochem; 2002 Feb; 80(3):548-51. PubMed ID: 11906000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense and splice site mutations in tau associated with FTDP-17: multiple pathogenic mechanisms.
    Hutton M
    Neurology; 2001 Jun; 56(11 Suppl 4):S21-5. PubMed ID: 11402146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.
    Wren MC; Zhao J; Liu CC; Murray ME; Atagi Y; Davis MD; Fu Y; Okano HJ; Ogaki K; Strongosky AJ; Tacik P; Rademakers R; Ross OA; Dickson DW; Wszolek ZK; Kanekiyo T; Bu G
    Mol Neurodegener; 2015 Sep; 10():46. PubMed ID: 26373282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrillogenesis of tau: insights from tau missense mutations in FTDP-17.
    Yen SH; Hutton M; DeTure M; Ko LW; Nacharaju P
    Brain Pathol; 1999 Oct; 9(4):695-705. PubMed ID: 10517508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of alternative splicing of human tau exon 10 by phosphorylation of splicing factors.
    Hartmann AM; Rujescu D; Giannakouros T; Nikolakaki E; Goedert M; Mandelkow EM; Gao QS; Andreadis A; Stamm S
    Mol Cell Neurosci; 2001 Jul; 18(1):80-90. PubMed ID: 11461155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17.
    Varani L; Hasegawa M; Spillantini MG; Smith MJ; Murrell JR; Ghetti B; Klug A; Goedert M; Varani G
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):8229-34. PubMed ID: 10393977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.
    Clark LN; Poorkaj P; Wszolek Z; Geschwind DH; Nasreddine ZS; Miller B; Li D; Payami H; Awert F; Markopoulou K; Andreadis A; D'Souza I; Lee VM; Reed L; Trojanowski JQ; Zhukareva V; Bird T; Schellenberg G; Wilhelmsen KC
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13103-7. PubMed ID: 9789048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5' splice site mutations in tau associated with the inherited dementia FTDP-17 affect a stem-loop structure that regulates alternative splicing of exon 10.
    Grover A; Houlden H; Baker M; Adamson J; Lewis J; Prihar G; Pickering-Brown S; Duff K; Hutton M
    J Biol Chem; 1999 May; 274(21):15134-43. PubMed ID: 10329720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural determinants for alternative splicing regulation of the MAPT pre-mRNA.
    Lisowiec J; Magner D; Kierzek E; Lenartowicz E; Kierzek R
    RNA Biol; 2015; 12(3):330-42. PubMed ID: 25826665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
    Dawson HN; Cantillana V; Chen L; Vitek MP
    J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in tau gene exon 10 associated with FTDP-17 alter the activity of an exonic splicing enhancer to interact with Tra2 beta.
    Jiang Z; Tang H; Havlioglu N; Zhang X; Stamm S; Yan R; Wu JY
    J Biol Chem; 2003 May; 278(21):18997-9007. PubMed ID: 12649279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau proteins with FTDP-17 mutations have a reduced ability to promote microtubule assembly.
    Hasegawa M; Smith MJ; Goedert M
    FEBS Lett; 1998 Oct; 437(3):207-10. PubMed ID: 9824291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments.
    Goedert M; Jakes R; Crowther RA
    FEBS Lett; 1999 May; 450(3):306-11. PubMed ID: 10359094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements.
    D'Souza I; Poorkaj P; Hong M; Nochlin D; Lee VM; Bird TD; Schellenberg GD
    Proc Natl Acad Sci U S A; 1999 May; 96(10):5598-603. PubMed ID: 10318930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant splicing of tau pre-mRNA caused by intronic mutations associated with the inherited dementia frontotemporal dementia with parkinsonism linked to chromosome 17.
    Jiang Z; Cote J; Kwon JM; Goate AM; Wu JY
    Mol Cell Biol; 2000 Jun; 20(11):4036-48. PubMed ID: 10805746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations.
    Goedert M; Satumtira S; Jakes R; Smith MJ; Kamibayashi C; White CL; Sontag E
    J Neurochem; 2000 Nov; 75(5):2155-62. PubMed ID: 11032905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of alternative splicing of tau in frontotemporal dementia and parkinsonism linked to chromosome 17.
    Kalbfuss B; Mabon SA; Misteli T
    J Biol Chem; 2001 Nov; 276(46):42986-93. PubMed ID: 11560926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.